BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 15070700)

  • 1. Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis.
    Bharti AC; Shishodia S; Reuben JM; Weber D; Alexanian R; Raj-Vadhan S; Estrov Z; Talpaz M; Aggarwal BB
    Blood; 2004 Apr; 103(8):3175-84. PubMed ID: 15070700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
    Bharti AC; Donato N; Singh S; Aggarwal BB
    Blood; 2003 Feb; 101(3):1053-62. PubMed ID: 12393461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells.
    Bhardwaj A; Sethi G; Vadhan-Raj S; Bueso-Ramos C; Takada Y; Gaur U; Nair AS; Shishodia S; Aggarwal BB
    Blood; 2007 Mar; 109(6):2293-302. PubMed ID: 17164350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells.
    Bharti AC; Donato N; Aggarwal BB
    J Immunol; 2003 Oct; 171(7):3863-71. PubMed ID: 14500688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.
    Bisping G; Kropff M; Wenning D; Dreyer B; Bessonov S; Hilberg F; Roth GJ; Munzert G; Stefanic M; Stelljes M; Scheffold C; Müller-Tidow C; Liebisch P; Lang N; Tchinda J; Serve HL; Mesters RM; Berdel WE; Kienast J
    Blood; 2006 Mar; 107(5):2079-89. PubMed ID: 16278310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating mutations in STAT3 and STAT5 differentially affect cellular proliferation and apoptotic resistance in multiple myeloma cells.
    Hodge DR; Xiao W; Wang LH; Li D; Farrar WL
    Cancer Biol Ther; 2004 Feb; 3(2):188-94. PubMed ID: 14726660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB.
    Yu Z; Zhang W; Kone BC
    Biochem J; 2002 Oct; 367(Pt 1):97-105. PubMed ID: 12057007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human anti-CD40 antagonist antibody triggers significant antitumor activity against human multiple myeloma.
    Tai YT; Li X; Tong X; Santos D; Otsuki T; Catley L; Tournilhac O; Podar K; Hideshima T; Schlossman R; Richardson P; Munshi NC; Luqman M; Anderson KC
    Cancer Res; 2005 Jul; 65(13):5898-906. PubMed ID: 15994968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bavachin induces the apoptosis of multiple myeloma cell lines by inhibiting the activation of nuclear factor kappa B and signal transducer and activator of transcription 3.
    Takeda T; Tsubaki M; Tomonari Y; Kawashima K; Itoh T; Imano M; Satou T; Nishida S
    Biomed Pharmacother; 2018 Apr; 100():486-494. PubMed ID: 29477912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cells.
    Dai Y; Pei XY; Rahmani M; Conrad DH; Dent P; Grant S
    Blood; 2004 Apr; 103(7):2761-70. PubMed ID: 14645003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanism.
    Dai Y; Landowski TH; Rosen ST; Dent P; Grant S
    Blood; 2002 Nov; 100(9):3333-43. PubMed ID: 12384435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of STAT3 and NF-κB activations by S-nitrosylation in multiple myeloma.
    Kim J; Choi S; Saxena N; Singh AK; Singh I; Won JS
    Free Radic Biol Med; 2017 May; 106():245-253. PubMed ID: 28232202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells.
    Kannaiyan R; Hay HS; Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Sharma A; Kumar AP; Chng WJ; Sethi G
    Br J Pharmacol; 2011 Nov; 164(5):1506-21. PubMed ID: 21506956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis.
    Ni H; Ergin M; Huang Q; Qin JZ; Amin HM; Martinez RL; Saeed S; Barton K; Alkan S
    Br J Haematol; 2001 Nov; 115(2):279-86. PubMed ID: 11703322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
    Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
    Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
    Catlett-Falcone R; Landowski TH; Oshiro MM; Turkson J; Levitzki A; Savino R; Ciliberto G; Moscinski L; Fernández-Luna JL; Nuñez G; Dalton WS; Jove R
    Immunity; 1999 Jan; 10(1):105-15. PubMed ID: 10023775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis.
    Kim SK; Park KY; Yoon WC; Park SH; Park KK; Yoo DH; Choe JY
    Joint Bone Spine; 2011 Oct; 78(5):471-7. PubMed ID: 21354845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.
    Li L; Aggarwal BB; Shishodia S; Abbruzzese J; Kurzrock R
    Cancer; 2004 Nov; 101(10):2351-62. PubMed ID: 15476283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.